Kathryn Lancaster to Hepatitis C
This is a "connection" page, showing publications Kathryn Lancaster has written about Hepatitis C.
Connection Strength
0.756
-
Lancaster KE, Malvestutto CD, Miller WC, Go VF. Commentary on Fraser et al. (2018): Evidence base for harm reduction services-the urban-rural divide. Addiction. 2018 Jan; 113(1):183-184.
Score: 0.539
-
Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
Score: 0.217